Diagnosed prevalent cases of chronic kidney disease to reach 22.97 million across 7MM in 2033, predicts GlobalData

Read more

Lupin receives approval from U.S. FDA for Topiramate Extended-Release Capsules

Read more

Pharma sector awaits Budget 2024 for innovation boost and regulatory reforms

Read more

Ozempic linked with lower dementia risk, nicotine use, British study finds

Read more

Synergistic safety profile could increase sublingual apomorphine competitiveness: GlobalData

Read more

Lupin receives EIR from U.S. FDA for its Dabhasa facility

Read more

Transforming medical device assembly with Acopos6D

Read more

Government drafts notification to regulate advertisements of schedule G drugs

Read more

The pharmaceutical retail industry: A paradigm shift for growth and compliance driven by data visibility

Read more

Antimicrobial Resistance and innovations shaping our future

Read more